MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 216 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,517,464 | -9.5% | 108,605 | -9.3% | 0.01% | -10.0% |
| Q1 2023 | $2,782,002 | +60.1% | 119,759 | 0.0% | 0.01% | +42.9% |
| Q4 2022 | $1,737,703 | -9.0% | 119,759 | +19.6% | 0.01% | -12.5% |
| Q3 2022 | $1,910,000 | +5.0% | 100,094 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $1,819,000 | -27.9% | 100,094 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $2,522,000 | -8.7% | 100,094 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,763,000 | +10.1% | 100,094 | +28.8% | 0.01% | 0.0% |
| Q3 2021 | $2,509,000 | -9.8% | 77,688 | -14.6% | 0.01% | -11.1% |
| Q2 2021 | $2,781,000 | +7.3% | 90,941 | +6.9% | 0.01% | 0.0% |
| Q1 2021 | $2,591,000 | +72.7% | 85,096 | -35.7% | 0.01% | +50.0% |
| Q2 2020 | $1,500,000 | +12.1% | 132,244 | +41.4% | 0.01% | 0.0% |
| Q1 2020 | $1,338,000 | -47.4% | 93,499 | 0.0% | 0.01% | -40.0% |
| Q4 2019 | $2,546,000 | -0.5% | 93,499 | +4.6% | 0.01% | 0.0% |
| Q3 2019 | $2,560,000 | – | 89,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
| Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
| ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
| EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
| AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
| Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
| Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |